PT-141 (Bremelanotide) - 10mg

PT-141 (Bremelanotide) is a synthetic peptide developed by Palatin Technologies. It's an analogue of the melanocyte-stimulating hormone (α-MSH) and is known for treating sexual dysfunctions in both men and women. The peptide works by stimulating melanocortin and xanthine receptors, which enhances libido and sexual desire. 

Peptide Profile

• Peptide Name: PT-141 (Bremelanotide)
• Main Function: Enhances sexual function and libido.
• Mechanism of Action: Stimulates melanocortin receptors, indirectly influencing sexual arousal.
• Key Features & Benefits:
  - Libido Enhancement: Remarkably increases sexual desire in both men and women.
  - Improved Sexual Function: Aids in erectile function and sexual satisfaction.
  - Mood Enhancement: Positive effects on mood and on depressive symptoms.
• Use Case: Primarily for treating sexual dysfunctions.
• Effects on Body Systems:
  - Blood Sugar: No known impact.
  - Appetite: No known impact.
  - Muscle Growth: No known impact.
  - Endurance & Weight Loss: No known impact.
  - Injury Repair & Healing: No known impact.
  - Joints & Anti-Aging: No known impact.
  - Sleep & Mood: Potential positive effects on mood and sleep.
• Recommended Dosage: Starting dose is 400 micrograms (mcg).

Correct intake and dosage

PT-141 (Bremelanotide) is a peptide used for treating sexual dysfunctions in men and women, acting as a libido stimulant.

The dosage of PT-141 can vary depending on the individual needs.

• Usual Starting Dose: 400 micrograms (mcg) to 700 micrograms (mcg), with effects lasting from 1 to 6 hours. The recommended regimen is to administer 8 units subcutaneously up to 7 hours before sexual activity, preferably in the evening, and an additional 5 units in the morning. The expected effect lasts for the next 30 hours. An alternative regimen involves administering 10-12 units a few hours before sexual activity.

One pen contains 200 units at 50 micrograms each. 1 unit of the pen equals 50 micrograms (mcg).

Example conversions of PT-141 units in a pen (10 mg) to micrograms are as follows:

• 1 unit = 50 mcg;
• 5 units = 250 mcg;
• 10 units = 500 mcg;
• 12 units = 600 mcg;
• 15 units = 750 mcg.

What is PT-141?

PT-141 (Bremelanotide) is a peptide developed by Palatin Technologies that acts as an agonist of the melanocortin receptor MC1, using it to treat various sexual dysfunctions and other health issues.

Bremelanotide is the synthetic analogue of the melanocyte-stimulating hormone (α-MSH), which stimulates melanin production in the skin. PT-141 was created as a treatment for sexual dysfunction, and it is also used for the treatment of other medical problems.

PT-141 acts as a stimulant of melanocyte receptors and xanthine receptors. This helps to increase libido and sexual desire in both men and women. This peptide aids in improving erectile function in men and helps in the treatment of various types of sexual dysfunctions in women.

Research on Bremelanotide PT-141 continues for its positive impact on depression, mental health, chronic pain, hormonal imbalance, and other health issues.

What are the benefits?

PT-141 (Bremelanotide) is a peptide that aids sexual function in both women and men. The application of PT-141 has the following benefits:

• PT-141 enhances libido and increases sexual desire in both men and women.
• PT-141 improves erectile function in men and helps improve blood circulation in the genitals.
• Peptide PT-141 enhances sexual sensations and increases the achievement of a more pleasant orgasm.
• PT-141 does not affect mental health and does not cause a feeling of euphoria.
• Peptide PT-141 is used in the treatment of various sexual dysfunctions in women and men, as an alternative to other medicinal products.
• PT-141 leads to improved self-esteem and confidence during sexual contact.
• It does not cause any adverse effects on the body and psyche of the person taking it.
• It is beneficial in female sexual dysfunction, improving experience and sexual desire.
• PT-141 has a positive effect on post-traumatic stress disorder, reducing feelings of fear, anxiety, and restlessness.
• PT-141 peptide has a rapid action, and the effect of its intake is observed within hours.

Clinical trials and their results

PT-141 is used to assist sexual function in men and women. Multiple clinical trials prove its positive effect in treating sexual dysfunctions.

In a clinical trial conducted in 2000 by Dr. Hula Claudel, women suffering from hypersexual disorder participated. Participants were divided into two groups, with the first group treated with PT-141 and the second with a placebo. Results show that women taking peptide PT-141 experienced a higher level of sexual desire and greater satisfaction from sexual activity.

In 2004, another clinical study involved 21 men suffering from erectile dysfunction. The application of PT-141 showed a significantly higher level of sexual stimulation, more prolonged erection, and overall improvement in sexual function.

In 2010, a third study on the impact of PT-141 was published in the "Journal of Sexual Medicine". In this study, 327 women suffering from hypersexual disorder participated. The application of PT-141 to the participants resulted in improved sexual satisfaction, desire, and activity.

Possible side effects

PT-141 is a medicinal product that positively affects sexual dysfunctions in men and women. Like any medicinal product, its use can also result in some side effects. These are associated with headaches, nausea, skin irritations, and an increase in blood pressure.

These side effects are mild and usually subside within a few days. Consulting a specialist when experiencing any of these symptoms is recommended.

Adhering to the prescribed dose and application instructions from a specialist is essential to avoid more serious side effects.

Conclusion

PT-141 (Bremelanotide), a synthetic peptide developed by Palatin Technologies, represents a significant advancement in the treatment of sexual dysfunctions. Its unique mechanism of action, stimulating melanocortin and xanthine receptors, enhances libido and sexual desire effectively in both men and women. Clinical trials have consistently shown its efficacy, making it a promising option for those seeking to improve their sexual health.

Key Takeaways

• Effective for Both Genders: PT-141 is beneficial in enhancing sexual function in both men and women.
• Mechanism of Action: It works by stimulating melanocortin receptors, which play a key role in sexual arousal.
• Wide Range of Benefits: Increases libido, improves erectile function, enhances sexual satisfaction, and positively affects mood.
• Proven Efficacy in Clinical Trials: Studies have shown significant improvement in sexual desire and function in participants.
• Minimal Side Effects: Side effects like headaches, nausea, and skin irritations are generally mild and transient.

FAQs

1. How quickly does PT-141 start working?
   - PT-141 typically begins to show effects within 1 to 6 hours after administration.
2. Can PT-141 be used as a long-term treatment?
   - While PT-141 can be used for ongoing treatment, it's important to do so under the guidance of a professional to monitor its effects and adjust dosages as necessary.
3. Are there any specific groups who should avoid using PT-141?
   - Individuals with certain medical conditions, particularly those related to heart health or blood pressure, should consult with a professional before using PT-141.
4. Is PT-141 only for individuals with diagnosed sexual dysfunction?
   - While PT-141 is primarily used for treating sexual dysfunctions, it may also be beneficial for individuals looking to enhance their sexual experience. 
5. How is PT-141 administered?
   - PT-141 is typically administered via subcutaneous injection.

Why to choose Nordic Peptides?

For those seeking high-quality PT-141 (Bremelanotide), Nordic Peptides is a reputable European source. The company specializes in producing very pure peptides, ensuring top-notch quality.